<?xml version="1.0" encoding="UTF-8" standalone="yes"?><getRegulatorySnapshotOutput id="74370"><Title>FDA Workshop (Agenda): Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine), 05-Dec-2007</Title><Versions><Version>None</Version></Versions><Status>Valid</Status><Abstract>This document contains the agenda for a workshop held on December 05,2007 in Rockville, Maryland. The purpose of the workshop was to solicit comments on a proposed rule that would amend FDA's regulation on the use of ozone-depleting substances in self-pressurized containers to remove the essential-use designation for oral pressurized metered-dose inhalers containing epinephrine. The proposed rule was published in the Federal Register of September 20, 2007 (see IDRAC &lt;Link type="Regulatory" id="72783"&gt;72783&lt;/Link&gt;).</Abstract><Region>USA</Region><Languages><language>English</language></Languages><Number>74370</Number><DocCategories><DocCategory>Reference Document</DocCategory></DocCategories><ProdCategories><ProdCategory>Drugs and Biologics</ProdCategory><ProdCategory>Medical Devices and IVDs</ProdCategory></ProdCategories><DocTypes><DocType>Meeting</DocType></DocTypes><Source>Obtained from the FDA website.&lt;br/&gt;www.fda.gov</Source><DateDisplay>5-Dec-2007</DateDisplay><DocForm>0</DocForm><AddedDate>04-Dec-2007</AddedDate><LastUpdatedDate>26-May-2015 18:24:30</LastUpdatedDate><Topics><Topic>Environment</Topic><Topic>Regulatory Procedures</Topic></Topics><MedicalDeviceSpecialties/></getRegulatorySnapshotOutput>